Studying tumorigenic cells separated in vitro, from malignant human breast cancer-derived pleural effusions, Al Hajj and colleagues isolated a cell population characterized by high CD44 expression and low or undetectable levels of CD24 (CD44+/CD24−/low). This evidence concerns the gene CD44 and breast cancer.